MBB 196 Undergraduate Seminar: A Prostrate-ing Problem and Synergistic Solutions

Prostate cancer remains one of the most common and deadliest cancers in the Philippines and globally. While treatments like androgen-deprivation therapy are widely used, prostatic tumors often recur, develop resistance, and progress into a more aggressive phenotype. To address this, synergistic drug combinations are currently being explored as strategies for a more effective prostate cancer treatment.

Join us this Friday, April 25, 2025, at 1:00 pm in NIMBB Room 105 for a discussion on novel therapeutic approaches for prostate cancer treatment with a focus on the synergy of endosomal recycling inhibitors (ERI) and enzalutamide. Gain valuable insights on how this combination may be translated into clinical practice.

See you then!